Quick info
3-MMC is a synthetic cathinone of the amphetamine group and closely related to mephedrone/4-MMC. The substance was developed as an analogue after the prohibition of 4-MMC and belongs to the little researched New Psychoactive Substances.
The effect is described as euphoric, empathogenic, relaxing, increasing concentration and performance, and stimulating. Compared to 4-MMC, 3-MMC is less empathogenic, but extremely stimulating and libido-enhancing. In addition, the craving is very pronounced and the dependence potential is significantly higher than with other empathogens such as MDMA or methylone.
Onset of action
Snorted: after 10-20 minutes
Swallowed: after 30-60 minutes
Duration of action
Snorted: 2.5-4.5 hours
Swallowed: 4-6 hours
Snorted
Light: 20-40 mg
Medium: 40-60 mg
Heavy: 60-120 mg
Ingested
Light: 50-150 mg
Medium: 150-250 mg
Heavy: 250-350 mg
Little is known about intravenous, rectal, and inhalation use. These forms of consumption should be avoided. If you do try any of these forms of consumption, dose as low as possible.AppearancesCrystalline Powder
Craving can be very pronounced when using 3-MMC, and the potential for dependence is thus high.
Other side effects may include dehydration (lack of fluid in the body), increase in blood pressure, suppression of bodily functions (hunger, thirst, and urination), nausea, paranoia, psychotic episodes (at high doses), severe craving, constriction of blood vessels, cardiovascular problems, circulation problems (cold hands and feet), sexual dysfunction, depressive moods, possible neuro- and cardiotoxic effects, and listlessness.
3-MMC is a new psychoactive substance. To date, nothing is known about the exact mechanisms of action, toxicity and possible long-term effects. The current state of knowledge is based almost exclusively on reports from users. Due to the strong craving (irresistible and uncontrollable desire to consume), especially when sniffing or smoking the substance, there is a risk that it will be taken too quickly and the side effects will predominate.
LSD analogues are substances that are chemically very similar to LSD and can have comparable effects. Some of them have been known for a long time (e.g. ALD52, ETH-LAD, AL-LAD, PRO-LAD etc.) and have been studied pharmacologically as well as psychopharmacologically, at least in part. Others are newer "creations" (e.g. the derivatives 1P-LSD,1B-LSD, 1cP-LSD, 1V-LSDetc.), for which only few or no data are available. Certain LSD analogues can (still) be legally produced, traded and consumed in some countries, which is the main reason for their distribution.
Most LSD analogues are naturally different from LSD in their effect and/or potency (e.g. ETH-LAD, AL-LAD, LSZ etc.). In contrast, the so-called 1-acylated LSD compounds (e.g. 1P-LSD, 1V-LSD, 1B-LSD, ALD-52, etc.) are presumed, on the basis of pharmacological studies, to convert into LSD in the body (they function as so-called prodrugs) and thus have a comparable psychoactive effect to LSD.
In the case of prodrugs of LSD and LSD analogues, it has not been conclusively clarified whether, in addition to their psychoactive effect, they can produce other pharmacological effects. How potent these prodrugs are compared to the resulting substance (e.g., 1P-LSD to LSD), and to what extent a delay in onset of action occurs in each case, may be substance-dependent and cannot be generalized. Therefore, it is important to approach the dose/effect carefully to avoid overdoses.
If you or someone else needs urgent help after taking drugs or alcohol, call an ambulance on 144. Tell the emergency responders everything you know.
It could save lives.